Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Rize Oncology Inc (RIZE.CN)

Rize Oncology Inc (RIZE.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Rize Oncology Inc 301-1665 Ellis Street c/o Pushor Mitchell LLP Kelowna BC V1Y 2B3 CAN

https://www.rizeoncology.com

Sector:

N/A

INDUSTRY GROUPING:

N/A

Description:

Rize Oncology Inc is is a biopharmaceutical company. The company is focused on the development of high-efficiency precision gene editing for human therapeutics applications. The company is also engaged in oncology, particularly soft tissue sarcoma, introduced by the recent exclusive licensing of STS-201, delivering small molecules targeting soft tissue sarcoma and other cancers.

Key Statistics

Overview:

Market Capitalization, $K 2,272
Shares Outstanding, K 75,745

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -551 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -170 K

Growth:

1-Year Return 20.00%
3-Year Return 0.00%
5-Year Return 0.00%

Per-Share Information:

Next Earnings Date N/A
Earnings Per Share ttm -0.01
EPS Growth vs. Prev Year 0.00%
Dividend Payout Ratio 0.00%

RIZE.CN Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -44.40%
Return-on-Assets % -42.33%
Profit Margin % 0.00%
Debt/Equity N/A
Price/Sales N/A
Price/Book 1.48
Book Value/Share 0.02
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.